https://ab-science.excalibra.com/ 2026-08-05T12:25:34+00:00 https://ab-science.excalibra.com/fr/ 2026-08-05T21:12:50+02:00 https://ab-science.excalibra.com/wp-content/uploads/2026/08/AB-SCIENCE_Programmes_prioritaires.png https://ab-science.excalibra.com/masivet/ 2020-10-13T13:18:03+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/masivet_success_story-1.jpg https://ab-science.excalibra.com/investors/regulated-information/leaders-statement/ 2020-10-31T10:20:55+00:00 https://ab-science.excalibra.com/themencode-pdf-viewer/ 2020-10-31T12:17:52+00:00 https://ab-science.excalibra.com/themencode-pdf-viewer-sc/ 2020-10-31T12:17:52+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/severe-asthma/ 2020-11-02T15:24:33+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/11/Primary-analysis-%E2%80%93-Severe-asthma-exacerbations.png https://ab-science.excalibra.com/careers/clinical-project-manager/ 2020-11-04T15:34:14+00:00 https://ab-science.excalibra.com/careers/clinical-data-analyst/ 2020-11-04T15:35:14+00:00 https://ab-science.excalibra.com/careers/scientific-and-medical-writer/ 2020-11-04T15:36:16+00:00 https://ab-science.excalibra.com/careers/senior-biostatistician-m-f/ 2020-11-04T15:37:14+00:00 https://ab-science.excalibra.com/careers/data-manager-m-f/ 2020-11-04T15:37:56+00:00 https://ab-science.excalibra.com/bientot-le-site-ab-science-com-en-francais/ 2020-11-05T16:15:30+00:00 https://ab-science.excalibra.com/news-and-media/ 2020-11-05T19:57:22+00:00 https://ab-science.excalibra.com/investors/regulated-information/ 2020-11-05T20:18:45+00:00 https://ab-science.excalibra.com/company/ 2020-11-05T20:29:39+00:00 https://ab-science.excalibra.com/careers/ 2020-11-05T23:52:54+00:00 https://ab-science.excalibra.com/investors/stock-information/ 2021-01-04T15:08:01+00:00 https://ab-science.excalibra.com/information-boursiere/ 2021-01-04T15:11:25+00:00 https://ab-science.excalibra.com/investors/events/ 2021-01-04T15:28:49+00:00 https://ab-science.excalibra.com/fr/investisseurs/ 2021-01-04T17:49:31+00:00 https://ab-science.excalibra.com/investisseurs/informations-reglementees-2/ 2021-01-04T17:59:06+00:00 https://ab-science.excalibra.com/fr/investisseurs/informations-reglementees/ 2021-01-04T19:18:58+00:00 https://ab-science.excalibra.com/actualites-et-media/replay-des-webconferences/ 2021-01-05T13:15:32+00:00 https://ab-science.excalibra.com/fr/actualites-et-media/ 2021-01-05T13:20:53+00:00 https://ab-science.excalibra.com/covid-19/ 2021-01-05T14:35:23+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/pancreatic-cancer/ 2021-01-05T15:01:43+00:00 https://ab-science.excalibra.com/masitinib-overview/ 2021-01-05T22:25:41+00:00 https://ab-science.excalibra.com/masitinib-overview-2/ 2021-01-05T22:25:43+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/masitinib_ab_science.png https://ab-science.excalibra.com/apercu-de-lentreprise-2/ 2021-01-05T23:13:57+00:00 https://ab-science.excalibra.com/fr/societe/ 2021-01-06T00:17:24+00:00 https://ab-science.excalibra.com/fr/masivet/ 2021-01-06T00:21:47+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/masivet_success_story-1.jpg https://ab-science.excalibra.com/science/ab8939-in-oncology/ 2021-01-06T00:53:47+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/tumour_prostate_w1920.jpg https://ab-science.excalibra.com/masitinib-en-oncologie/ 2021-01-06T01:10:49+00:00 https://ab-science.excalibra.com/science/masitinib-in-neurodegenerative-disorders/ 2021-01-06T15:35:58+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/neurodegenerative_disorders_1920-1.jpg https://ab-science.excalibra.com/science/ 2021-01-06T15:42:47+00:00 https://ab-science.excalibra.com/fr/carrieres/chef-de-projet-clinique-h-f/ 2021-01-13T12:29:00+00:00 https://ab-science.excalibra.com/fr/science/le-masitinib-dans-les-troubles-neurodegeneratifs/ 2021-01-20T15:08:50+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/neurodegenerative_disorders_1920-1.jpg https://ab-science.excalibra.com/fr/carrieres/ 2021-01-20T15:31:49+00:00 https://ab-science.excalibra.com/fr/investisseurs/information-boursiere/ 2021-01-20T15:51:52+00:00 https://ab-science.excalibra.com/fr/investisseurs/evenements/ 2021-01-20T15:58:46+00:00 https://ab-science.excalibra.com/fr/science/ab8939-en-oncologie/ 2021-01-21T15:02:38+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/tumour_prostate_w1920.jpg https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/cancer-du-pancreas/ 2021-01-21T15:06:48+00:00 https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/asthme-severe/ 2021-01-21T15:10:22+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/11/Primary-analysis-%E2%80%93-Severe-asthma-exacerbations.png https://ab-science.excalibra.com/fr/contact/ 2021-08-24T13:09:55+00:00 https://ab-science.excalibra.com/contact/ 2021-08-24T13:25:05+00:00 https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/covid-19/ 2021-10-06T10:05:51+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/covid-19/ 2021-10-06T10:14:33+00:00 https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/ 2021-10-20T13:05:16+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/masitinib_ab_science.png https://ab-science.excalibra.com/subscribe-to-our-mailing-list/ 2021-11-25T16:07:21+00:00 https://ab-science.excalibra.com/fr/inscrivez-vous-a-notre-liste-de-diffusion/ 2021-11-25T16:56:11+00:00 https://ab-science.excalibra.com/fr/masivet/informations-medicales-et-pharmacovigilance/ 2021-12-14T17:31:53+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/masivet_success_story-1.jpg https://ab-science.excalibra.com/masivet/medical-information-and-pharmacovigilance/ 2021-12-14T17:32:26+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/masivet_success_story-1.jpg https://ab-science.excalibra.com/list-of-centers-participating-in-the-study-in-amyotrophic-lateral-sclerosis/ 2022-05-09T08:13:25+00:00 https://ab-science.excalibra.com/fr/liste-des-centres-participant-a-l-etude-sur-la-sclerose-laterale-amyotrophique/ 2022-05-09T08:49:05+00:00 https://ab-science.excalibra.com/fr/societe/comite-scientifique/ 2022-07-25T21:36:21+00:00 https://ab-science.excalibra.com/company/scientific-committee/ 2022-07-25T21:36:48+00:00 https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/cancer-de-la-prostate/ 2022-08-23T11:55:58+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/prostate-cancer/ 2022-08-23T11:56:51+00:00 https://ab-science.excalibra.com/fr/science/publications/ 2022-08-24T17:10:04+00:00 https://ab-science.excalibra.com/science/publications/ 2022-08-24T17:12:48+00:00 https://ab-science.excalibra.com/pipeline/ab8939-acute-myeloid-leukemia/ 2022-11-21T13:44:20+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/11/Hermine-2020-EHA2020.png https://ab-science.excalibra.com/fr/pipeline/ab8939-leucemie-myeloide-aigue/ 2022-11-21T13:45:03+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/11/Hermine-2020-EHA2020.png https://ab-science.excalibra.com/company/values/ 2023-05-23T22:40:06+00:00 https://ab-science.excalibra.com/fr/societe/valeurs/ 2023-05-23T22:45:41+00:00 https://ab-science.excalibra.com/investors/regulated-information/regulated-agreements/ 2023-05-31T16:21:29+00:00 https://ab-science.excalibra.com/fr/investisseurs/informations-reglementees/conventions-reglementees/ 2023-05-31T16:21:47+00:00 https://ab-science.excalibra.com/masivet/about-masivet/ 2023-11-22T13:12:21+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/masivet_success_story-1.jpg https://ab-science.excalibra.com/fr/masivet/a-propos-de-masivet/ 2023-11-22T13:13:43+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/masivet_success_story-1.jpg https://ab-science.excalibra.com/fr/investisseurs/informations-reglementees/responsabilites-sociales-et-environnementales/ 2024-02-29T08:15:24+00:00 https://ab-science.excalibra.com/investors/regulated-information/social-and-environmental-responsabilities/ 2024-02-29T08:22:53+00:00 https://ab-science.excalibra.com/fr/actualites-et-media/conferences-virtuelles/ 2025-03-07T10:34:49+00:00 https://ab-science.excalibra.com/news-and-media/webcasts/ 2025-03-07T10:37:17+00:00 https://ab-science.excalibra.com/fr/investisseurs/informations-reglementees/reglement-interieur-du-conseil-d-administration/ 2025-04-23T08:51:10+00:00 https://ab-science.excalibra.com/investors/regulated-information/board-of-directors-charter/ 2025-04-23T08:51:18+00:00 https://ab-science.excalibra.com/fr/actualites-et-media/dans-les-media/ 2025-05-13T08:36:24+00:00 https://ab-science.excalibra.com/wp-content/uploads/2021/02/2021-02-11-L_Express-11022021-Covid-19-Les-biotechs-franc%CC%A7aises-se-font-une-place-dans-la-course-aux-traitements.png https://ab-science.excalibra.com/wp-content/uploads/2021/02/2021-02-12-Pharmaceutiques-Janvier-2021-2020-anne%CC%81e-du-masitinib.jpg https://ab-science.excalibra.com/wp-content/uploads/2021/01/2021_01_28_Blastingnews_FR.png https://ab-science.excalibra.com/wp-content/uploads/2020/12/23-12-2020_Boursorama.jpg https://ab-science.excalibra.com/wp-content/uploads/2020/11/2020_11_30_Les_Echos.png https://ab-science.excalibra.com/news-and-media/in-the-media/ 2025-05-13T08:36:31+00:00 https://ab-science.excalibra.com/wp-content/uploads/2021/02/2021-02-11-L_Express-11022021-Covid-19-Les-biotechs-franc%CC%A7aises-se-font-une-place-dans-la-course-aux-traitements.png https://ab-science.excalibra.com/wp-content/uploads/2021/02/2021-02-12-Pharmaceutiques-Janvier-2021-2020-anne%CC%81e-du-masitinib.jpg https://ab-science.excalibra.com/wp-content/uploads/2021/01/2021_01_26_Blastingnews-1.png https://ab-science.excalibra.com/wp-content/uploads/2020/12/23-12-2020_Boursorama.jpg https://ab-science.excalibra.com/wp-content/uploads/2020/11/2020_11_30_Les_Echos.png https://ab-science.excalibra.com/fr/science/ 2025-05-21T10:34:45+00:00 https://ab-science.excalibra.com/science/ 2025-05-21T10:34:50+00:00 https://ab-science.excalibra.com/fr/science/le-masitinib-dans-les-maladies-inflammatoires/ 2025-05-21T11:30:23+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/09/medic-563423-scaled-e1602489345330.jpg https://ab-science.excalibra.com/science/masitinib-in-inflammatory-diseases/ 2025-05-21T11:30:29+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/09/medic-563423-scaled-e1602489345330.jpg https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/sclerose-en-plaques/ 2025-05-21T13:11:46+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/Primary-analysis-%E2%80%93-Change-in-EDSS-up-to-week-96-Positive-value-indicates-worsening-1.png https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/sclerose-laterale-amyotrophique/ 2025-05-21T13:11:52+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/11/Primary-analysis-%E2%80%93-Change-in-ALSFRS-score-from-baseline.png https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/maladie-alzheimer/ 2025-05-21T13:11:56+00:00 https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/mastocytose-systemique-indolente/ 2025-05-21T13:12:02+00:00 https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/syndrome-d-activation-des-mastocytes/ 2025-05-21T13:12:07+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/mast-cell-activation-syndrome/ 2025-05-21T13:13:22+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/indolent-systemic-mastocytosis/ 2025-05-21T13:13:28+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/alzheimer-disease/ 2025-05-21T13:13:32+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/multiple-sclerosis/ 2025-05-21T13:13:45+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/Primary-analysis-%E2%80%93-Change-in-EDSS-up-to-week-96-Positive-value-indicates-worsening-1.png https://ab-science.excalibra.com/fr/investisseurs/pourquoi-investir-dans-ab-science/ 2025-05-21T13:16:19+00:00 https://ab-science.excalibra.com/investors/why-invest-in-ab-science/ 2025-05-21T13:16:45+00:00 https://ab-science.excalibra.com/company/corporate-overview/ 2025-05-21T13:18:44+00:00 https://ab-science.excalibra.com/fr/societe/vue-d-ensemble-de-la-societe/ 2025-05-21T13:18:50+00:00 https://ab-science.excalibra.com/investors/regulated-information/half-year-reports/ 2025-10-10T16:11:54+00:00 https://ab-science.excalibra.com/fr/investisseurs/informations-reglementees/rapports-semestriels/ 2025-10-10T16:13:04+00:00 https://ab-science.excalibra.com/investors/regulated-information/information-document/ 2025-10-17T14:56:23+00:00 https://ab-science.excalibra.com/fr/investisseurs/informations-reglementees/document-information/ 2025-10-17T14:58:55+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/amyotrophic-lateral-sclerosis/ 2025-11-05T14:35:15+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/11/Primary-analysis-%E2%80%93-Change-in-ALSFRS-score-from-baseline.png https://ab-science.excalibra.com/fr/actualites-et-media/communiques-de-presse/ 2026-01-07T18:08:08+00:00 https://ab-science.excalibra.com/news-and-media/press-releases/ 2026-01-07T18:14:39+00:00 https://ab-science.excalibra.com/fr/investisseurs/analystes-financiers/ 2026-02-03T13:05:48+00:00 https://ab-science.excalibra.com/wp-content/uploads/2018/05/logo_sf_01.jpg https://ab-science.excalibra.com/investors/analyst-coverage/ 2026-02-03T13:13:21+00:00 https://ab-science.excalibra.com/wp-content/uploads/2018/05/logo_sf_01.jpg https://ab-science.excalibra.com/fr/investisseurs/informations-reglementees/rapports-annuels/ 2026-05-13T17:36:42+00:00 https://ab-science.excalibra.com/investors/regulated-information/annual-financial-reports/ 2026-05-21T07:22:16+00:00 https://ab-science.excalibra.com/fr/investisseurs/informations-reglementees/actions-en-circulation-et-droits-de-vote/ 2026-06-02T10:11:56+00:00 https://ab-science.excalibra.com/investors/regulated-information/monthly-disclosure-of-total-outstanding-shares-and-voting-rights/ 2026-06-02T10:12:18+00:00 https://ab-science.excalibra.com/investors/regulated-information/articles-of-incorporation/ 2026-06-30T13:20:48+00:00 https://ab-science.excalibra.com/fr/investisseurs/informations-reglementees/statuts/ 2026-06-30T13:21:04+00:00 https://ab-science.excalibra.com/investors/regulated-information/shareholders-general-meeting/ 2026-07-01T11:35:19+00:00 https://ab-science.excalibra.com/fr/investisseurs/informations-reglementees/assemblees-generales-des-actionnaires/ 2026-07-01T11:35:26+00:00 https://ab-science.excalibra.com/fr/societe/comite-executif/ 2026-07-22T13:26:43+00:00 https://ab-science.excalibra.com/wp-content/uploads/2018/05/alain_moussy.jpg https://ab-science.excalibra.com/company/executive-commitee/ 2026-07-22T13:26:56+00:00 https://ab-science.excalibra.com/wp-content/uploads/2018/05/alain_moussy.jpg https://ab-science.excalibra.com/fr/science/masitinib-drepanocytose/ 2026-07-31T11:48:38+00:00 https://ab-science.excalibra.com/wp-content/uploads/2026/07/Mecanisme-daction-du-masitinib-dans-la-drepanocytose.jpg https://ab-science.excalibra.com/science/masitinib-in-sickle-cell-disease/ 2026-07-31T11:49:23+00:00 https://ab-science.excalibra.com/wp-content/uploads/2026/07/Mecanisme-daction-du-masitinib-dans-la-drepanocytose.jpg https://ab-science.excalibra.com/fr/pipeline/masitinib-apercu/etude-clinique-masitinib-drepanocytose/ 2026-07-31T12:19:55+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/masitinib-sickle-cell-disease-clinical-study/ 2026-07-31T12:26:09+00:00 https://ab-science.excalibra.com/investors/investor-kit/ 2026-07-31T12:29:40+00:00 https://ab-science.excalibra.com/wp-content/uploads/2026/01/AB-Science_Corporate_Presentation_Jan_2026.png https://ab-science.excalibra.com/fr/investisseurs/kit-investisseurs/ 2026-07-31T12:30:22+00:00 https://ab-science.excalibra.com/wp-content/uploads/2026/01/AB-Science_Corporate_Presentation_Jan_2026.png https://ab-science.excalibra.com/fr/investisseurs/calendrier-financier/ 2026-07-31T12:32:27+00:00 https://ab-science.excalibra.com/investors/financial-calendar/ 2026-07-31T12:32:39+00:00 https://ab-science.excalibra.com/pipeline/masitinib-overview/ 2026-07-31T12:35:17+00:00 https://ab-science.excalibra.com/wp-content/uploads/2020/10/masitinib_ab_science.png https://ab-science.excalibra.com/pipeline/ 2026-07-31T12:42:07+00:00 https://ab-science.excalibra.com/wp-content/uploads/2025/05/Pipeline_2025_EN.jpg https://ab-science.excalibra.com/fr/pipeline/ 2026-07-31T12:43:25+00:00 https://ab-science.excalibra.com/wp-content/uploads/2025/05/Pipeline_2025_EN.jpg